Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis  A cross-sectional study at a tertiary care teaching hospital

Kena Jasani; Pranjal Jain; Dhiren Patel; Sapan Pandya; Devang A Rana; Supriya D Malhotra

doi:10.5455/njppp.2020.10.1137119122019

2024, Vol: 14, Issue: 10

14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 30 Dec 2019

Natl J Physiol Pharm Pharmacol. 2020; 10(2): 168-172

doi: 10.5455/njppp.2020.10.1137119122019

Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital

Kena Jasani, Pranjal Jain, Dhiren Patel, Sapan Pandya, Devang A Rana, Supriya D Malhotra.

Cited By:3

Abstract
Background: Rheumatoid arthritis (RA) is the most common autoimmune arthritis and it affects 1% of the adult population in India. It is an inflammatory disease which leads to bilateral joint pain and swelling. The swelling destroys joints and results in permanent deformities like ankylosis.

Aims and Objectives: The objectives of this study were to study and evaluate the prescribing pattern in patients suffering from RA and to evaluate the quality of life (QoL) in RA patients.

Materials and Methods: After getting permission from the Indian Council of Medical Research and Institutional Review Board, the study was started. Informed consent form of individual patient was obtained. All the patients of either sex attending rheumatology department and diagnosed with RA and receiving antirheumatoid drugs for 1 month were matriculate in the study and patients suffering along with osteoarthritis, and the newly diagnosed patient was excluded from the study.

Results: A total of 50 patients were enrolled for the study which shows middle-aged people suffered more with female dominance and mostly used drug being methotrexate and hydroxychloroquine. RAQoL average being 17 which showed impaired QoL. Prescribing pattern in RA relied more on disease-modifying antirheumatoid agents.

Conclusion: Commonly used drugs were disease-modifying antirheumatoid agents. It was found that the majority of the cost is borne by the patient as there are few drugs available at the hospital pharmacy which can be given free. Polypharmacy was common, being the cost burden to the patients.

Key words: Disease-modifying Antirheumatoid Drugs; Quality of Life; Rheumatoid Arthritis

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Kena Jasani Articles by Pranjal Jain Articles by Dhiren Patel Articles by Sapan Pandya Articles by Devang A Rana Articles by Supriya D Malhotra
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Jasani K, Jain P, Patel D, Pandya S, Rana DA, Malhotra SD. Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. 2020; 10(2): 168-172. doi:10.5455/njppp.2020.10.1137119122019

Web Style

Jasani K, Jain P, Patel D, Pandya S, Rana DA, Malhotra SD. Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital. https://www.njppp.com/?mno=75159 [Access: November 01, 2024]. doi:10.5455/njppp.2020.10.1137119122019

AMA (American Medical Association) Style

Jasani K, Jain P, Patel D, Pandya S, Rana DA, Malhotra SD. Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. 2020; 10(2): 168-172. doi:10.5455/njppp.2020.10.1137119122019

Vancouver/ICMJE Style

Jasani K, Jain P, Patel D, Pandya S, Rana DA, Malhotra SD. Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. (2020), [cited November 01, 2024]; 10(2): 168-172. doi:10.5455/njppp.2020.10.1137119122019

Harvard Style

Jasani, K., Jain, . P., Patel, . D., Pandya, . S., Rana, . D. A. & Malhotra, . S. D. (2020) Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol, 10 (2), 168-172. doi:10.5455/njppp.2020.10.1137119122019

Turabian Style

Jasani, Kena, Pranjal Jain, Dhiren Patel, Sapan Pandya, Devang A Rana, and Supriya D Malhotra. 2020. Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 10 (2), 168-172. doi:10.5455/njppp.2020.10.1137119122019

Chicago Style

Jasani, Kena, Pranjal Jain, Dhiren Patel, Sapan Pandya, Devang A Rana, and Supriya D Malhotra. "Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 168-172. doi:10.5455/njppp.2020.10.1137119122019

MLA (The Modern Language Association) Style

Jasani, Kena, Pranjal Jain, Dhiren Patel, Sapan Pandya, Devang A Rana, and Supriya D Malhotra. "Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 10.2 (2020), 168-172. Print. doi:10.5455/njppp.2020.10.1137119122019

APA (American Psychological Association) Style

Jasani, K., Jain, . P., Patel, . D., Pandya, . S., Rana, . D. A. & Malhotra, . S. D. (2020) Evaluation of drug use pattern and quality of life in patients suffering from rheumatoid arthritis A cross-sectional study at a tertiary care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 10 (2), 168-172. doi:10.5455/njppp.2020.10.1137119122019

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article